Showing 221 - 240 results of 310 for search '"Bordeaux University"', query time: 0.11s Refine Results
  1. 221
  2. 222
  3. 223
  4. 224
  5. 225
  6. 226
  7. 227
  8. 228
  9. 229

    Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study by M. Lahouati, C. Cazanave, A. Labadie, P. Gohier, L. Guirlé, A. Desclaux, M. Gigan, D. Malvy, S. Pedeboscq, F. Xuereb, A. Duvignaud, The Bordeaux COVID-19 Treatment Group

    Published 2023-09-01
    “…All immunocompromised patients aged 18 or more, with asymptomatic SARS-CoV-2 infection or mild COVID-19, and who had received a targeted treatment with sotrovimab, tixagevimab/cilgavimab, nirmatrelvir/ritonavir or remdesivir at the Bordeaux University Hospital from 1st January 2022 to 31st December 2022 were eligible. …”
    Get full text
    Article
  10. 230
  11. 231
  12. 232
  13. 233
  14. 234
  15. 235
  16. 236
  17. 237
  18. 238
  19. 239
  20. 240